Cargando…
Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer’s Disease
BACKGROUND: Beta-site APP cleaving enzyme 1 (BACE1) is the rate-limiting enzyme in amyloid-β (Aβ) plaques formation. BACE1 activity is increased in brains of patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI) and plasma levels of BACE1 appears to reflect those in the brains....
Autores principales: | Nicsanu, Roland, Cervellati, Carlo, Benussi, Luisa, Squitti, Rosanna, Zanardini, Roberta, Rosta, Valentina, Trentini, Alessandro, Ferrari, Clarissa, Saraceno, Claudia, Longobardi, Antonio, Bellini, Sonia, Binetti, Giuliano, Zanetti, Orazio, Zuliani, Giovanni, Ghidoni, Roberta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198762/ https://www.ncbi.nlm.nih.gov/pubmed/35275540 http://dx.doi.org/10.3233/JAD-215542 |
Ejemplares similares
-
Plasma Extracellular Vesicle Size and Concentration Are Altered in Alzheimer’s Disease, Dementia With Lewy Bodies, and Frontotemporal Dementia
por: Longobardi, Antonio, et al.
Publicado: (2021) -
Cerebrospinal Fluid EV Concentration and Size Are Altered in Alzheimer’s Disease and Dementia with Lewy Bodies
por: Longobardi, Antonio, et al.
Publicado: (2022) -
Exploring Neurofilament Light Chain and Exosomes in the Genetic Forms of Frontotemporal Dementia
por: Zanardini, Roberta, et al.
Publicado: (2022) -
Plasma Small Extracellular Vesicles with Complement Alterations in GRN/C9orf72 and Sporadic Frontotemporal Lobar Degeneration
por: Bellini, Sonia, et al.
Publicado: (2022) -
N-Terminally Truncated and Pyroglutamate-Modified Aβ Forms Are Measurable in Human Cerebrospinal Fluid and Are Potential Markers of Disease Progression in Alzheimer’s Disease
por: Domingo, Guido, et al.
Publicado: (2021)